Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	26.29	30.78	109.28	52.25	31.8
Short-Term Investments	99.72	116.14	46.04	71.02	59.04
Cash & Cash Equivalents	126	146.91	155.32	123.27	90.83
Cash Growth	-14.23%	-5.41%	26.00%	35.71%	-27.11%
Receivables	1.78	1.35	0.9	1.31	1.2
Other Current Assets	4.25	2.87	4.45	3.12	1.79
Total Current Assets	132.03	151.14	160.66	127.7	93.83
Property, Plant & Equipment	6.09	6.81	8.08	9.33	11.41
Long-Term Investments	6.28	37.36	35.69	0	0
Other Long-Term Assets	0	0.1	0.06	0.04	0.29
Total Long-Term Assets	12.37	44.28	43.82	9.38	11.71
Total Assets	144.4	195.42	204.49	137.08	105.54
Accounts Payable	10.27	16.03	10.84	9.15	7.24
Deferred Revenue	11.79	22.46	0	0	0
Current Debt	0.43	0.37	0.38	0.39	0.34
Other Current Liabilities	0	-6	0	0	0.25
Total Current Liabilities	22.49	32.86	11.22	9.54	7.83
Long-Term Debt	1.34	1.82	2.23	2.59	3.02
Other Long-Term Liabilities	14.55	23.9	21.59	22.98	21.95
Total Long-Term Liabilities	15.9	25.71	23.83	25.57	24.96
Total Liabilities	38.38	58.57	35.05	35.11	32.79
Total Debt	1.77	2.19	2.61	2.98	3.36
Debt Growth	-19.16%	-16.34%	-12.37%	-11.17%	-
Retained Earnings	-1,276.65	-1,203.8	-1,134.35	-1,045.96	-970.09
Comprehensive Income	-48.42	-50.49	-48.34	-48.17	-48.23
Shareholders' Equity	106.02	136.85	169.44	101.97	72.74
Net Cash / Debt	124.24	144.73	152.7	120.29	87.48
Net Cash / Debt Growth	-14.16%	-5.22%	26.95%	37.51%	-29.80%
Net Cash Per Share	0.75	0.96	1.44	1.59	1.53
Working Capital	109.54	118.28	149.44	118.16	86
Book Value Per Share	0.64	0.91	1.59	1.34	1.27

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).